Skip to content

The Effect of Thyroid Antibodies on Female Reproductive Function and Pregnancy Outcomes

The Effect of Thyroid Antibodies on Female Reproductive Function and Pregnancy Outcomes

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04952012
Enrollment
4000
Registered
2021-07-07
Start date
2020-11-30
Completion date
2022-11-30
Last updated
2021-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroiditis, Autoimmune

Brief summary

Some women at reproductive age have positive antithyroid antibodies (ATAs). Thyroid peroxidase antibody (TPOAb) and thyroglobulin antibody (TgAb) are the most common ATAs. This study aimed to evaluate the impact of ATAs on maturation of women reproductive system and pregnancy outcomes.

Interventions

DRUGLT4

LT4 is used to improve the thyroid function of pregnant women.

Sponsors

First People's Hospital of Yuhang
CollaboratorUNKNOWN
Taizhou Women and Children's Hospital Affiliated to Wenzhou Medical University
CollaboratorUNKNOWN
Changxing People's Hospital
CollaboratorOTHER
Second Affiliated Hospital, School of Medicine, Zhejiang University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Age during 18-45y; * Women tested for TPOAb and/or TgAb, TSH, free T3, free T4, total T3 and total T4 during the 1st trimester of pregnancy

Exclusion criteria

* Multiple pregnancies; * Age \< 18 y or \> 40 y; * L-T4 or PTU intervention before pregnancy; * Other autoimmune diseases.

Design outcomes

Primary

MeasureTime frame
Incidence rate of pregnancy complications in women with or without thyroid antibodies1 year

Countries

China

Contacts

Primary ContactMin Jin
min_jin@zju.edu.cn057187783759

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026